Skip to content
Home
Expertise
Data
Collaborations
Resource Library
Menu
Home
Expertise
Data
Collaborations
Resource Library
CONTACT
Publications
home
publications
How Representative are the Patients Included in the CV outcome Trials with SGLT2 Inhibitors of a General Type 2 Diabetes Population? A Large European Observational study
Share this article